Photodynamic therapy with methyl-aminolevulinate can be useful in the management of Scytalidium infections.
C
C
Aspiroz
B
B
Fortuño-Cebamanos
A
A
Rezusta
Y
Y
Gilaberte
D000622:Aminolevulinic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy; D060085:Coinfection; D003131:Combined Modality Therapy; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008875:Middle Aged; D003904:Mitosporic Fungi / Q000187:drug effects*; D014009:Onychomycosis / Q000188:drug therapy* / Q000382:microbiology; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*
D000935:Antifungal Agents; D007093:Imidazoles; D017319:Photosensitizing Agents; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid; C036596:bifonazole